Chongqing Pharscin Pharmaceutical Co Ltd Strategic Asset Allocation Index
Chongqing Pharscin Pharmaceutical Co Ltd strategic asset allocation index. Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Strategic Asset Allocation Index of 37.1% as of September 2023. Strategic assets (PP&E of CN¥605.79 Million plus long-term investments of CN¥-) total CN¥605.79 Million, measured against net assets of CN¥1.63 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Chongqing Pharscin Pharmaceutical Co Ltd (002907) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Chongqing Pharscin Pharmaceutical Co Ltd (2016–2021)
Strategic asset allocation index of Chongqing Pharscin Pharmaceutical Co Ltd from 2016 to 2021. This chart shows how Chongqing Pharscin Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of September 2023, the index stands at 37.1%, representing strategic assets of CN¥605.79 Million against net assets of CN¥1.63 Billion CNY. Check how tangible is Chongqing Pharscin Pharmaceutical Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Chongqing Pharscin Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2016–2021)
Chongqing Pharscin Pharmaceutical Co Ltd strategic asset allocation index by year from 2016 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Chongqing Pharscin Pharmaceutical Co Ltd from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Chongqing Pharscin Pharmaceutical Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 51.7% | CN¥654.21 Million | CN¥654.21 Million | CN¥- | CN¥1.27 Billion | ▼ -5.3 pp |
| 2020 | 57.0% | CN¥673.61 Million | CN¥673.61 Million | CN¥- | CN¥1.18 Billion | ▼ -1.7 pp |
| 2019 | 58.7% | CN¥629.05 Million | CN¥629.05 Million | CN¥- | CN¥1.07 Billion | ▲ +20.2 pp |
| 2018 | 38.5% | CN¥319.51 Million | CN¥319.51 Million | CN¥- | CN¥828.91 Million | ▲ +6.2 pp |
| 2017 | 32.4% | CN¥233.12 Million | CN¥233.12 Million | CN¥- | CN¥719.95 Million | ▼ -3.0 pp |
| 2016 | 35.4% | CN¥163.33 Million | CN¥163.33 Million | CN¥- | CN¥461.42 Million | — |